Bristol-Myers beats Street 2Q forecasts
The New York-based company said it had net income of 56 cents per share. Earnings, adjusted for non-recurring costs, came to 74 cents per share.
from Biotech News
The New York-based company said it had net income of 56 cents per share. Earnings, adjusted for non-recurring costs, came to 74 cents per share.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments